Ablation should be 1st line therapy in the high risk Brugada Syndrome patient - Rebuttal PRO
20 March 2018 (09:00 - 09:05)
Organised by:
11 More presentations in this session
Professor V. Probst (Nantes, FR)
Professor S. Viskin (Tel Aviv, IL)
Access the full session
The Event
EHRA 2018
20 March 2018
09:00 CET
